The Annual Report for the financial year 2024-25 has been attached herewith.
Awaiting price reaction for this filing.
Dharti Proteins Ltd has filed its 31st Annual Report for FY 2024-25. The company underwent Corporate Insolvency Resolution Process (CIRP) under IBC 2016, admitted by NCLT Ahmedabad on April 29, 2024, with a financial creditor filing the application. A new Resolution Professional was appointed on February 4, 2025, and the resolution plan received NCLT approval on November 18, 2025. New management took over on December 19, 2025, and is now completing delayed statutory compliances. During FY 2024-25, the company had zero revenue from operations due to prolonged inoperative status, with other income of Rs. 7.20 Lakhs and a net loss of Rs. 0.66 Lakhs (improved from Rs. 19.01 Lakhs loss in prior year). Auditors raised going concern doubts, flagged Rs. 150.46 Lakhs in potentially bad debts, and noted multiple compliance failures including suspended BSE listing since August 2015.
Shareholders should note that while the company has been revived through CIRP, it has been non-operational for years with suspended listing and significant compliance gaps. The post-CIRP revival offers potential recovery value, but the stock remains illiquid and high-risk given historical financial distress and ongoing stabilization efforts.